SMU-B is an orally active inhibitor of ALK (IC50 < 0.5 nM), c-ros oncogene 1 (ROS1), c-MET (IC50 = 1.87 nM), and AXL (IC50 = 28.9 nM); it inhibits the proliferation of MKN45, H1993, and H441 cells with IC50 values of 0.02 μM, 1.58 μM, and 2.82 μM, respectively; and demonstrates antitumor activity in mouse models.